Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets

[1]  S. Trottier,et al.  Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine. , 2021, The New England journal of medicine.

[2]  N. Sardesai,et al.  Intradermal SynCon® Ebola GP DNA Vaccine is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. , 2019, The Journal of infectious diseases.

[3]  K. Chandran,et al.  Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus , 2019, npj Vaccines.

[4]  J. Derisi,et al.  Taxonomy of the order Bunyavirales: second update 2018 , 2019, Archives of Virology.

[5]  Su-Jin Park,et al.  Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis , 2018, Nature Microbiology.

[6]  Su-Jin Park,et al.  Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention , 2018, Clinical and experimental vaccine research.

[7]  M. Shimojima,et al.  A neutralization assay with a severe fever with thrombocytopenia syndrome virus strain that makes plaques in inoculated cells. , 2017, Journal of virological methods.

[8]  H. Ebihara,et al.  Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection , 2017, Front. Microbiol..

[9]  Y. Miyasako,et al.  Severe Fever with Thrombocytopenia Syndrome , 2016, Internal medicine.

[10]  J. Mascola,et al.  Rapid development of a DNA vaccine for Zika virus , 2016, Science.

[11]  C. Schmaljohn,et al.  A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. , 2016, Vaccine.

[12]  N. Sardesai,et al.  Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device. , 2015, Human gene therapy methods.

[13]  D. X. Li,et al.  Severe fever with thrombocytopenia syndrome: a newly discovered emerging infectious disease. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  Guillermo Posadas-Herrera,et al.  Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection , 2015, Virology.

[15]  J. Liu,et al.  A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  Xue-Jie Yu,et al.  Severe fever with thrombocytopenia syndrome and its pathogen SFTSV. , 2015, Microbes and infection.

[17]  E. Shin,et al.  Relationship between Poor Immunogenicity of HLA-A2-Restricted Peptide Epitopes and Paucity of Naïve CD8+ T-Cell Precursors in HLA-A2-Transgenic Mice , 2014, Immune network.

[18]  M. Han,et al.  Severe Fever with Thrombocytopenia Syndrome Virus in Ticks Collected from Humans, South Korea, 2013 , 2014, Emerging infectious diseases.

[19]  M. Shimojima,et al.  The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan , 2013, The Journal of infectious diseases.

[20]  R. Tesh,et al.  The Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus Infection in Alpha/Beta Interferon Knockout Mice: Insights into the Pathologic Mechanisms of a New Viral Hemorrhagic Fever , 2013, Journal of Virology.

[21]  P. G. Choe,et al.  Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012 , 2013, Emerging infectious diseases.

[22]  Donald K Carter,et al.  Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. , 2013, The Journal of infectious diseases.

[23]  Hao Yu,et al.  An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV , 2013, Science China Life Sciences.

[24]  N. Sardesai,et al.  Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation , 2013, Vaccines.

[25]  Bian-Li Xu,et al.  Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. , 2013, The Journal of infectious diseases.

[26]  K. H. Khan.  DNA vaccines: roles against diseases. , 2013, Germs.

[27]  Z. Bi,et al.  Critical Epitopes in the Nucleocapsid Protein of SFTS Virus Recognized by a Panel of SFTS Patients Derived Human Monoclonal Antibodies , 2012, PloS one.

[28]  Shiwen Wang,et al.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model , 2012, Proceedings of the National Academy of Sciences.

[29]  Ming-hui Li,et al.  Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. , 2012, The Journal of general virology.

[30]  Weizhong Yang,et al.  Fever with thrombocytopenia associated with a novel bunyavirus in China. , 2011, The New England journal of medicine.

[31]  R. Moss,et al.  Journal of Immune Based Therapies and Vaccines Prospects for Control of Emerging Infectious Diseases with Plasmid Dna Vaccines History of Dna Vaccines , 2022 .

[32]  T. M. Pertmer,et al.  DNA Vaccines for Influenza Virus: Differential Effects of Maternal Antibody on Immune Responses to Hemagglutinin and Nucleoprotein , 2000, Journal of Virology.